Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01465763
Other study ID # A3921094
Secondary ID 2011-004578-27OC
Status Completed
Phase Phase 3
First received October 21, 2011
Last updated August 24, 2015
Start date April 2012
Est. completion date May 2015

Study information

Verified date August 2015
Source Pfizer
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

This study is designed to evaluate the efficacy and safety of tofacitinib (CP-690,550) in patients with moderate to severe ulcerative colitis who have failed or be intolerant to one of following treatments for ulcerative colitis: oral steroids, azathiopurine/6-mercaptopurine, or anti-TNF-alpha therapy.


Recruitment information / eligibility

Status Completed
Enrollment 614
Est. completion date May 2015
Est. primary completion date May 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Subject must be at least 18 years of age.

- Males and females with a documented diagnosis of UC at least 4 months prior to entry into the study.

- Subjects with moderately to severely active UC based on Mayo score criteria.

- Subjects must have failed or be intolerant of at least one of the following treatments for UC:

- Corticosteroids (oral or intravenous).

- Azathioprine or 6 mercaptopurine (6 MP).

- Anti TNF-alpha therapy.

Exclusion Criteria:

- Presence of indeterminate colitis, microscopic colitis, ischemic colitis, infectious colitis, or clinical findings suggestive of Crohn's disease.

- Subjects with disease limited to distal 15 cm.

- Subjects without previous treatment for UC (ie, treatment naïve).

- Subjects displaying clinical signs of fulminant colitis or toxic megacolon.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
tofacitinib
10 mg oral BID
Placebo
Plabebo oral BID

Locations

Country Name City State
Australia Eastern Health Box Hill Victoria
Australia Royal Prince Alfred Hospital Camperdown New South Wales
Australia Nepean Hospital Kingswood New South Wales
Austria AKH Wien, Universitaetsklinik fuer Innere Medizin III, Wien
Belgium UZ Leuven (University Hospital Leuven), Campus Gasthuisberg Leuven
Canada Hertiage Medical Research Clinic- University Of Calgary Calgary Alberta
Canada HHSC, McMaster Hospital Site Hamilton Ontario
Canada London Health Sciences Centre - University Hospital London Ontario
Canada Hopital Maisonneuve-Rosemont Montreal Quebec
Colombia Unidad de Gastroenterologia y Endoscopia Digestiva S.A. - UGASEND S.A. Barranquilla Atlantico
Croatia General Hospital Zadar Zadar
Czech Republic Hepato-Gastroenterologie HK, s.r.o. Hradec Kralove
Czech Republic Institut klinicke a experimentalni mediciny Praha 4
Czech Republic Klinicke Centrum ISCARE I.V.F. Praha 7
Denmark Aalborg Hospital Aalborg
Denmark Aalborg Hospital Department of Medical Gastroenterology Aalborg
Denmark Aarhus University Hospital Aarhus C
Estonia West Tallinn Central Hospital Internal Diseases Clinic Tallinn
France CHU de Nantes - Hotel Dieu Nantes
France Hopital Saint-Louis Paris
France Hopital Rangueil Toulouse Cedex 9
Germany Charite Campus Virchow-Klinikum Universitaetsmedizin Berlin Medizinische Klinik mit Schwerpunkt Gast Berlin
Germany Universitaetsklinikum Halle (Saale) Halle
Germany Medizinische Hochschule Hannover Hannover
Germany Klinikum Luneburg/Abteilung Gastroenterologie Lüneburg
Hungary Szent Margit Korhaz III Belgyogyaszati Gasztroenterologiai Osztaly Budapest
Hungary Pecsi Tudomanyegyetem Klinikai Kozpont Pecs
Hungary Szegedi Tudomanyegyetem Altalanos Orvostudomanyi Kar I. sz. Belgyogyaszati Klinika Szeged
Hungary Javorszky Odon Korhaz/Gasztroenterologiai Osztaly Vac
Israel Rabin Medical Center, Beilinson campus Petah Tikva
Israel Tel Aviv Sourasky Medical Center Tel Aviv
Italy SOC Gastroenterologia Centro di Riferimento Oncologico Aviano
Italy AOU Mater Domini - U.O. Fisiopatologia Digestiva Catanzaro CZ
Italy Ibd Center Irccs Humanitas Milan
Italy A.O.R. Villa Sofia- Cervello Palermo PA
Italy Comitato Etico Palermo 2 Palermo PA
Italy Ospedali Riuniti Villa Sofia Cervello Palermo
Japan Chiba University Hospital Chiba-shi Chiba
Japan Fukuoka University Chikushi Hospital Fukuoka
Japan Tokai University Hachioji Hospital Hachioji Tokyo
Japan National Hospital Organization Mito Medical Center Higashi-ibaraki-gun Ibaraki
Japan National Hospital Organization Hirosaki National Hospital Hirosaki Aomori
Japan Hiroshima University Hospital Hiroshima
Japan The Hospital of Hyogo College of Medicine Hyogo
Japan Sameshima Hospital Kagoshima
Japan Kuniyoshi Hopital Kochi
Japan Kurume University Hospital Kurume-shi Fukuoka
Japan Jikei University Hospital Minato-ku Tokyo
Japan Kitasato University Kitasato Institute Hospital Minato-ku Tokyo
Japan Aichi Medical University Hospital Nagakute Aichi
Japan Osaka City University Hospital Osaka
Japan Shiga University Of Medical Science Otsu Shiga
Japan Toho University Sakura Medical Center Sakura Chiba
Japan Hokkaido P.W.F.A.C Sapporo-Kosei general Hospital Sapporo Hokkaido
Japan National Hospital Organization Sendai Medical Center Sendai Miyagi
Japan NTT Medical Center Tokyo Shinagawa-ku Tokyo
Japan Showa University Hospital Shinagawa-ku Tokyo
Japan Osaka Medical College Hospital Takatsuki Osaka
Japan Keio University Hospital Tokyo
Japan Tokyo Medical And Dental University Hospital, Faculty of Medicine Tokyo
Latvia Digestive Diseases Center GASTRO Riga
Latvia ECG room, Clinic "Linezers" Riga
Latvia X-Ray Department, Clinic "Linezers" Riga
Netherlands Leiden University Medical Center (LUMC) Leiden ZH
New Zealand Southern District Health Board Dunedin
New Zealand Shakespeare Specialist Group Milford Auckland
New Zealand Bop Clinical School Clinical Trials Unit Tauranga
New Zealand Tauranga Hospital Tauranga Bay of Plenty
Poland Gabinet Lekarski - Janusz Rudzinski Bydgoszcz Kujawsko-pomorskie
Poland Oddzial Kliniczny Gastroenterologii Ogolnej i Onkologicznej Lodz
Poland Klinika Chorob Wewnetrznych i Gastroenterologii z Pododdzialem Leczenia Warszawa Mazowieckie
Poland Lexmedica Wroclaw
Romania Cabinet Particular Policlinic Algomed SRL Timisoara Jud Timis
Russian Federation State budgetInstitution ofHealthcare Nizhniy NovgorodRegionalClinicalHospital namedafterN.A.Semashko Nizhniy Novgorod
Russian Federation Federal State Institution "Sibirian regional Medical Centre of Federal Medicobiologic Agency" Novosibirsk
Russian Federation Municipal budget institution of healthcare of Novosibirsk "City Clinical Hospital Novosibirsk
Russian Federation State Budget Educational Institution of Higher Professional Education Novosibirsk
Russian Federation Municipal budget institution of healthcare "Central City Hospital of Pyatigorsk" Pyatigorsk Stavropol region
Russian Federation GBOU VPO "Northwest State Medical Academy n.a. I.I. Mechnikov" Saint Petersburg
Russian Federation GUZ City Hospital #26 Saint Petersburg
Russian Federation Limited Liability Company Medical Company "Hepatolog" Samara Russia
Russian Federation Non-State Healthcare Institution "Road Clinical Hispital at the station Samara" of Open Joint-Stock Samara
Russian Federation Samara Diagnostic center, X-ray Department Samara
Russian Federation Federal State Budgetary Military Educational Institution of High Professional Education St. Petersburg
Serbia Clinical Hospital Centre Zvezdara Belgrade
Serbia Military Medical Academy Belgrade Belgrade
Serbia Clinical Centre of Kragujevac Kragujevac
Serbia General Hospital "Djordje Joanovic" Department for Gastroenterology and Hepatology Zrenjanin Serbia, Europe
Slovakia HPL spol. s r.o. Bratislava
Slovakia Medak s.r.o. Bratislava
Slovakia Prevencia a zdravie s.r.o. Bratislava
South Africa Endocare Research Centre Cape Town Western Cape
South Africa Chris Hani Baragwanath Academic Hospital Johannesburg Gauteng
Spain Hospital Clinic I Provincial de Barcelona Barcelona
Spain Hospital Clinico San Carlos Madrid
Spain Hospital Universitario de Fuenlabrada Madrid
Spain Hospital Universitario La Princesa Madrid
Ukraine State Institution "National L.T. Malaya Therapy Institute of National Academy Kharkov
Ukraine Kyiv Municipal Clinical Hospital #18, Proctology Department Kyiv
Ukraine LTD "St. Paraskeva Medical Center" Lviv
Ukraine Municipal City Clinical Hospital of the Emergency Medical Care, 1-st Therapy Department of hospital, Lviv
Ukraine SI "Railway Hospital of the SI "Odesa Railway"", Polyclinic Department, Odesa
Ukraine InternalMedicineCenterofCrimean,GastroenterologicalDepartment,StateInstitution"CrimeanStateMedicalUn Simferopol AR Krym
Ukraine Local Laboratory of I.M.C. of Crimean Republic Institution "Clinical Territorial Medical Community " Simferopol AR Krym
Ukraine SI "District Clin. Hosp.of Uzhgorod station (STSA "Lviv Railway", Therapy Dep., SBHEI Uzhgorod
Ukraine Vinnytsia National Medical University Vinnytsia
Ukraine Vinnytsia Regional Clinical Hospital for Invalids of the Great Patriotic War, Therapy Department #2 Vinnytsya
United Kingdom Addenbrooke's Hospital Cambridge
United Kingdom University College Hospital London
United States Georgia Endoscopy Center (Colonoscopy only) Alpharetta Georgia
United States Florida Surgery Center Altamonte Springs Florida
United States East Ann Arbor Health and Geriatrics Center - University of Michigan Health Systems Ann Arbor Michigan
United States Medical Science Research Building 1 - University of Michigan Health Systems Ann Arbor Michigan
United States Michigan Clinical Research Unit - Univeristy of Michigan Health System Ann Arbor Michigan
United States Saint Joseph Mercy Hospital - Inpatient Pharmacy (Pharmacy Only) Ann Arbor Michigan
United States University of Michigan Health Systems Ann Arbor Michigan
United States GI Consultants (Colonoscopy only) Atlanta Georgia
United States Clevland Clinic Department of Pharmacy Cleveland Ohio
United States NYU Langone Long Island Clinical Research Associates Great Neck New York
United States NYU Langone Nassau Gastroenterology Associates Great Neck New York
United States Endoscopy Center of Connecticut, LLC Guilford Connecticut
United States Endoscopy Center of Connecticut, LLC Hamden Connecticut
United States Gastroenterology Center of Connecticut, PC Hamden Connecticut
United States Medical Research Center of Connecticut, LLC Hamden Connecticut
United States Sunrise Medical Labs Hicksville New York
United States Baylor College of Medicine - Baylor Medical Center (Drug Storage) Houston Texas
United States Baylor Medical Center Houston Texas
United States Gastroenterology Consultants, P.A. Houston Texas
United States Houston Hospital for Specialized Surgery Houston Texas
United States Emory Healthcare Heart Center (EKG) Johns Creek Georgia
United States Investigational Drug Pharmacy, UCSD Health System, Moores Cancer Center La Jolla California
United States UCSD Medical Center La Jolla California
United States Cedars Sinai Medical Center - Thalians Bldg Los Angeles California
United States Cedars-Sinai Medical Center Los Angeles California
United States Cedars-Sinai Medical Center - Inflammatory Bowel Disease Center Los Angeles California
United States CRC Office - Cedars-Sinai Medical Center - Inflammatory Bowel Disease Center Los Angeles California
United States MD Office - Cedars-Sinai Medical Center Suite 203 E Los Angeles California
United States Regulatory Office - Cedars-Sinai Medical Center - Imflammatory Bowel Disease Center Los Angeles California
United States Gastroenterology Associates of Central Georgia Macon Georgia
United States Center for Advanced Gastroenterology Maitland Florida
United States MNH Surgical Center Maitland Florida
United States Sand Lake Imaging Maitland Florida
United States Great Lakes Gastroenterology Mentor Ohio
United States Center for Digestive Health Milwaukee Wisconsin
United States Wisconsin Center for Advanced Research - GI Associates, LLC Milwaukee Wisconsin
United States Horizon Research Group, Inc. Mobile Alabama
United States Internal Medicine Center, LLC Mobile Alabama
United States Springhill Memorial Hospital Mobile Alabama
United States Columbia University Medical Center New York New York
United States CUMC Research Pharmacy New York New York
United States Icahn School of Medicine at Mount Sinai New York New York
United States Kornbluth, Legnani, George MD, PC New York New York
United States Mount Sinai Doctos Faculty Practice New York New York
United States The Private Practice of Simon Lichtiger, MD New York New York
United States Southwest Gastroenterology Oak Lawn Illinois
United States North Florida Gastroenterology Research, LLC Orange Park Florida
United States Orange Park Surgery Center Orange Park Florida
United States Citrus Ambulatory Surgery Center Orlando Florida
United States Internal Medicine Specialists Orlando Florida
United States Desert Advanced Imaging Palm Springs California
United States Erik Palmer, DO Palm Springs California
United States Homan A Zadeh, MD, MPH Palm Springs California
United States Hope Square Surgical Center Rancho Mirage California
United States Center for Advanced Medicine Saint Louis Missouri
United States Washington University School of Medicine - Division of Gastroenterology Saint Louis Missouri
United States Wasatch Clinical Research Salt Lake City Utah
United States Sharp Rees-Stealy San Diego California
United States Sharp Rees-Stealy Medical Group San Diego California
United States Atlanta Gastroenterology Specialists, PC Suwanee Georgia
United States Johns Creek Diagnostic Center (X-Ray only) Suwanee Georgia
United States Shafran Gastroenterology Center Winter Park Florida
United States Huron Gastroenterology Associates / Center for Digestive Care Ypsilanti Michigan
United States Michigan Heart SJMH Ypsilanti Michigan
United States Saint Joseph Mercy Hospital Outpatient Laboratory Ypsilanti Michigan
United States Florida Medical Clinic, P.A. Zephyrhills Florida

Sponsors (1)

Lead Sponsor Collaborator
Pfizer

Countries where clinical trial is conducted

United States,  Australia,  Austria,  Belgium,  Canada,  Colombia,  Croatia,  Czech Republic,  Denmark,  Estonia,  France,  Germany,  Hungary,  Israel,  Italy,  Japan,  Latvia,  Netherlands,  New Zealand,  Poland,  Romania,  Russian Federation,  Serbia,  Slovakia,  South Africa,  Spain,  Ukraine,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary The proportion of subjects in remission at Week 8. 8 weeks No
Secondary The proportion of subjects achieving mucosal healing at Week 8. 8 weeks No
Secondary The proportion of subjects achieving clinical response at Week 8. based on the Mayo score 8 weeks No
Secondary The proportion of subjects in clinical remission at Week 8. based on the Mayo score 8 weeks No
Secondary The proportion of subjects in symptomatic remission at Week 8. based on the Mayo score 8 weeks No
Secondary The proportion of subjects achieving deep remission at Week 8. based on the Mayo score 8 weeks No
Secondary Partial Mayo scores and change from baseline over time. 8 weeks No
Secondary Change from baseline at Week 8 in total Mayo score. 8 weeks No
See also
  Status Clinical Trial Phase
Recruiting NCT05702879 - Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success
Not yet recruiting NCT05953402 - A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
Recruiting NCT05316584 - A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy N/A
Recruiting NCT03950232 - An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis Phase 3
Completed NCT03124121 - Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels Phase 4
Not yet recruiting NCT06100289 - A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease Phase 3
Withdrawn NCT04209556 - A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis Phase 2
Terminated NCT00061282 - Clotrimazole Enemas for Pouchitis in Children and Adults Phase 1/Phase 2
Recruiting NCT04398550 - SCD vs. Mediterranean Diet Therapy in Ulcerative Colitis N/A
Recruiting NCT04314375 - Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis Phase 4
Active, not recruiting NCT04857112 - Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis Phase 2
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Active, not recruiting NCT04033445 - A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis Phase 2/Phase 3
Recruiting NCT05428345 - A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Active, not recruiting NCT06221995 - Energy Expenditure in Patients With Ulcerative Colitis Undergoing Surgery
Recruiting NCT04767984 - Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis Phase 2
Completed NCT02508012 - Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases N/A
Recruiting NCT06071312 - FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach Phase 1/Phase 2
Completed NCT03760003 - Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis Phase 2
Not yet recruiting NCT05539625 - Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis Phase 2